Which projects can be funded?
The funding covers a broad range of possible projects. It is guided by the specific needs of people affected by the disease and by the aim of improving their situation. Priority will be given to pilot projects on drug development and research projects focused on the development and validation of biomarkers. However, studies on the diagnosis, epidemiology, care, and basic science of ME/CFS—including laboratory studies—are also welcome. The type of study is not an exclusion criterion. Co-financing of studies that are already underway is possible.
What evaluation criteria will be applied?
The following criteria will be taken into account when applications are assessed:
- Scientific quality and relevance
- Methodology and study design
- Degree of innovation and potential forimpact
- Feasibility and resources
- Qualifications of the research team
- Patient orientation and ethicalconsiderations
- Publication and Open Science
Further information on the evaluation criteria can be found here.
Who can apply for funding?
Anyone planning or already conducting an ME/CFS research project and affiliated with an institution in Germany—whether a university, institute, or other public or private organisation—is eligible to apply.
